Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics

Masahito Horiuchi, Megumi Kimura, Miwa Tokumura, Nobuyoshi Hasebe, Tohko Arai, Koji Abe

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

β-Lactam antibiotics have been suggested to have some degree of convulsive activity and neurotoxicity in experimental animals as well as in clinical situations. We examined the convulsive activities of a new carbapenem antibiotic, (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(su lfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxic acid monohydrate (doripenem) using several animals and compared them with β-lactam antibiotics. In intravenous (IV) injection studies, imipenem/cilastatin, at 400/400 mg/kg produced seizure discharges on electroencephalogram (EEG) accompanied with clonic convulsions in rats. Meropenem showed only wet dog shaking behavior at 200 and 400 mg/kg. Doripenem caused no changes in the EEG and behavior in rats at 400 mg/kg. Imipenem/cilastatin IV potentiated the pentylenetetrazol (PTZ)-induced convulsions in mice at 250/250 mg/kg, while meropenem, panipenem/betamipron, cefazolin or doripenem did not cause any marked effects at up to 500 mg/kg. In mouse intracerebroventricular (ICV) injection studies, imipenem, panipenem and cefazolin induced clonic convulsions in a dose-dependent manner in mice. Doripenem and meropenem did not induce convulsions at up to 100 μg/mouse. In dog ICV injection studies, imipenem produced generalized seizure discharge with clonic convulsions at 100 μg/dog. Meropenem also produced spikes or seizure discharges at 100, 300 and 1000 μg/dog. However, doripenem had no effects on the EEG and behavior in dogs at any doses. In in vitro binding studies, imipenem, panipenem, cefazolin and meropenem inhibited [3H]muscimol binding to the GABAA receptor in mouse brain homogenates while doripenem did not cause any inhibition at up to 10 mM. In addition, doripenem had no influence on the anti-convulsant actions of valproic acid in the PTZ- or bicuculine-induced convulsive model. These results clearly indicate that doripenem has no convulsive activity, suggesting that its neurotoxicity may be negligible in clinical use.

Original languageEnglish
Pages (from-to)114-124
Number of pages11
JournalToxicology
Volume222
Issue number1-2
DOIs
Publication statusPublished - May 1 2006
Externally publishedYes

Fingerprint

doripenem
meropenem
Lactams
Carbapenems
Seizures
Anti-Bacterial Agents
Cefazolin
Dogs
Imipenem
Electroencephalography
Pentylenetetrazole
Rats
Animals
Convulsants
Muscimol
Injections
Valproic Acid
GABA-A Receptors
Intravenous Injections
Brain

Keywords

  • Carbapenem antibiotics
  • Convulsion
  • Doripenem
  • GABA receptor binding

ASJC Scopus subject areas

  • Toxicology

Cite this

Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. / Horiuchi, Masahito; Kimura, Megumi; Tokumura, Miwa; Hasebe, Nobuyoshi; Arai, Tohko; Abe, Koji.

In: Toxicology, Vol. 222, No. 1-2, 01.05.2006, p. 114-124.

Research output: Contribution to journalArticle

Horiuchi, Masahito ; Kimura, Megumi ; Tokumura, Miwa ; Hasebe, Nobuyoshi ; Arai, Tohko ; Abe, Koji. / Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. In: Toxicology. 2006 ; Vol. 222, No. 1-2. pp. 114-124.
@article{8c79e37ce3d04f7c8b57093ec14d968e,
title = "Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics",
abstract = "β-Lactam antibiotics have been suggested to have some degree of convulsive activity and neurotoxicity in experimental animals as well as in clinical situations. We examined the convulsive activities of a new carbapenem antibiotic, (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(su lfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxic acid monohydrate (doripenem) using several animals and compared them with β-lactam antibiotics. In intravenous (IV) injection studies, imipenem/cilastatin, at 400/400 mg/kg produced seizure discharges on electroencephalogram (EEG) accompanied with clonic convulsions in rats. Meropenem showed only wet dog shaking behavior at 200 and 400 mg/kg. Doripenem caused no changes in the EEG and behavior in rats at 400 mg/kg. Imipenem/cilastatin IV potentiated the pentylenetetrazol (PTZ)-induced convulsions in mice at 250/250 mg/kg, while meropenem, panipenem/betamipron, cefazolin or doripenem did not cause any marked effects at up to 500 mg/kg. In mouse intracerebroventricular (ICV) injection studies, imipenem, panipenem and cefazolin induced clonic convulsions in a dose-dependent manner in mice. Doripenem and meropenem did not induce convulsions at up to 100 μg/mouse. In dog ICV injection studies, imipenem produced generalized seizure discharge with clonic convulsions at 100 μg/dog. Meropenem also produced spikes or seizure discharges at 100, 300 and 1000 μg/dog. However, doripenem had no effects on the EEG and behavior in dogs at any doses. In in vitro binding studies, imipenem, panipenem, cefazolin and meropenem inhibited [3H]muscimol binding to the GABAA receptor in mouse brain homogenates while doripenem did not cause any inhibition at up to 10 mM. In addition, doripenem had no influence on the anti-convulsant actions of valproic acid in the PTZ- or bicuculine-induced convulsive model. These results clearly indicate that doripenem has no convulsive activity, suggesting that its neurotoxicity may be negligible in clinical use.",
keywords = "Carbapenem antibiotics, Convulsion, Doripenem, GABA receptor binding",
author = "Masahito Horiuchi and Megumi Kimura and Miwa Tokumura and Nobuyoshi Hasebe and Tohko Arai and Koji Abe",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.tox.2006.02.004",
language = "English",
volume = "222",
pages = "114--124",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics

AU - Horiuchi, Masahito

AU - Kimura, Megumi

AU - Tokumura, Miwa

AU - Hasebe, Nobuyoshi

AU - Arai, Tohko

AU - Abe, Koji

PY - 2006/5/1

Y1 - 2006/5/1

N2 - β-Lactam antibiotics have been suggested to have some degree of convulsive activity and neurotoxicity in experimental animals as well as in clinical situations. We examined the convulsive activities of a new carbapenem antibiotic, (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(su lfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxic acid monohydrate (doripenem) using several animals and compared them with β-lactam antibiotics. In intravenous (IV) injection studies, imipenem/cilastatin, at 400/400 mg/kg produced seizure discharges on electroencephalogram (EEG) accompanied with clonic convulsions in rats. Meropenem showed only wet dog shaking behavior at 200 and 400 mg/kg. Doripenem caused no changes in the EEG and behavior in rats at 400 mg/kg. Imipenem/cilastatin IV potentiated the pentylenetetrazol (PTZ)-induced convulsions in mice at 250/250 mg/kg, while meropenem, panipenem/betamipron, cefazolin or doripenem did not cause any marked effects at up to 500 mg/kg. In mouse intracerebroventricular (ICV) injection studies, imipenem, panipenem and cefazolin induced clonic convulsions in a dose-dependent manner in mice. Doripenem and meropenem did not induce convulsions at up to 100 μg/mouse. In dog ICV injection studies, imipenem produced generalized seizure discharge with clonic convulsions at 100 μg/dog. Meropenem also produced spikes or seizure discharges at 100, 300 and 1000 μg/dog. However, doripenem had no effects on the EEG and behavior in dogs at any doses. In in vitro binding studies, imipenem, panipenem, cefazolin and meropenem inhibited [3H]muscimol binding to the GABAA receptor in mouse brain homogenates while doripenem did not cause any inhibition at up to 10 mM. In addition, doripenem had no influence on the anti-convulsant actions of valproic acid in the PTZ- or bicuculine-induced convulsive model. These results clearly indicate that doripenem has no convulsive activity, suggesting that its neurotoxicity may be negligible in clinical use.

AB - β-Lactam antibiotics have been suggested to have some degree of convulsive activity and neurotoxicity in experimental animals as well as in clinical situations. We examined the convulsive activities of a new carbapenem antibiotic, (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(su lfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxic acid monohydrate (doripenem) using several animals and compared them with β-lactam antibiotics. In intravenous (IV) injection studies, imipenem/cilastatin, at 400/400 mg/kg produced seizure discharges on electroencephalogram (EEG) accompanied with clonic convulsions in rats. Meropenem showed only wet dog shaking behavior at 200 and 400 mg/kg. Doripenem caused no changes in the EEG and behavior in rats at 400 mg/kg. Imipenem/cilastatin IV potentiated the pentylenetetrazol (PTZ)-induced convulsions in mice at 250/250 mg/kg, while meropenem, panipenem/betamipron, cefazolin or doripenem did not cause any marked effects at up to 500 mg/kg. In mouse intracerebroventricular (ICV) injection studies, imipenem, panipenem and cefazolin induced clonic convulsions in a dose-dependent manner in mice. Doripenem and meropenem did not induce convulsions at up to 100 μg/mouse. In dog ICV injection studies, imipenem produced generalized seizure discharge with clonic convulsions at 100 μg/dog. Meropenem also produced spikes or seizure discharges at 100, 300 and 1000 μg/dog. However, doripenem had no effects on the EEG and behavior in dogs at any doses. In in vitro binding studies, imipenem, panipenem, cefazolin and meropenem inhibited [3H]muscimol binding to the GABAA receptor in mouse brain homogenates while doripenem did not cause any inhibition at up to 10 mM. In addition, doripenem had no influence on the anti-convulsant actions of valproic acid in the PTZ- or bicuculine-induced convulsive model. These results clearly indicate that doripenem has no convulsive activity, suggesting that its neurotoxicity may be negligible in clinical use.

KW - Carbapenem antibiotics

KW - Convulsion

KW - Doripenem

KW - GABA receptor binding

UR - http://www.scopus.com/inward/record.url?scp=33744989013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744989013&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2006.02.004

DO - 10.1016/j.tox.2006.02.004

M3 - Article

C2 - 16549226

AN - SCOPUS:33744989013

VL - 222

SP - 114

EP - 124

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-2

ER -